CUTANEOUS LYMPHOMA FOUNDATION

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1998

Legal Domicile

Principal Officer

DAVID ELEFANT

Phone

2486449014

Tax Period

2024-07-01 to 2025-06-30

CUTANEOUS LYMPHOMA FOUNDATION, founded in 1998, is a small nonprofit in the Diseases & Disorders sector that reported $837K in total revenue in fiscal year 2024. Revenue grew 12% year-over-year, indicating healthy expansion. Expenses of $1.1M exceeded revenue, resulting in a 29% operating deficit.

Mission

THE CUTANEOUS LYMPHOMA FOUNDATION IS AN INDEPENDENT, NON-PROFIT PATIENT ADVOCACY ORGANIZATION DEDICATED TO SUPPORTING PATIENTS WITH CUTANEOUS LYMPHOMAS BY PROMOTING AWARENESS AND EDUCATION, ADVANCING PATIENT CARE AND FACILITATING RESEARCH.

Program Service Accomplishments

Program 1

Expenses: $913,760

PATIENT ADVOCACY ORGANIZATION DEDICATED TO SUPPORTING PATIENTS WITH MYCOSIS FUNGOIDES, SEZARY SYNDROME AND OTHER FORMS OF CUTANEOUS LYMPHOMAS BY PROMOTING AWARENESS AND EDUCATION, ADVANCING PATIENT...

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $824,953

Program Service Revenue $0

Investment Income $11,880

Other Revenue $0

TOTAL REVENUE $836,833

Expense Breakdown

Grants Paid $65,500

Salaries & Benefits $642,699

Fundraising Expenses $54,339

Program Expenses $913,760

Other Expenses $370,715

TOTAL EXPENSES $1,078,914

Year-over-Year Comparison

	2024	2023	Change
Revenue	$836,833	$746,138	+0.1%
Expenses	$1,078,914	$925,624	+0.2%
Net Income	$-242,081	$-179,486	+0.3%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
SUSAN THORNTON	CHIEF EXEC O	N/A	Highest	$139,000	$0	$139,000
MARIANNE TAWA RN MSN ANP	SECRETARY	5.00	Officer Director	$0	$0	$0
MADDY CURRY	TRUSTEE/DIRE	5.00	Director	$0	$0	$0
DAVID ELEFANT	PRESIDENT	5.00	Officer Director	$0	$0	$0
ROBERT HULSE	TRUSTEE/DIRE	5.00	Director	$0	$0	$0
RICK KITCHEN	DIRECTOR	5.00	Director	$0	$0	$0
STEVEN HORWITZ MD	DIRECTOR	5.00	Director	$0	$0	$0
YOUN KIM MD	DIRECTOR	5.00	Director	$0	$0	$0
KELLY PAUL	TRUSTEE/DIRE	5.00	Director	$0	$0	$0
RICHARD TOLSMA	VICE PRESIDE	5.00	Officer Director	$0	$0	$0
BYRON VIELEHR	TREASURER	5.00	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$836,833	$1,078,914	$936,554	$-242,081
2024	$746,138	$925,624	$1,203,956	$-179,486
2023	$575,949	$958,034	$1,406,163	$-382,085
2022	$943,674	$732,001	$1,694,712	$211,673
2021	$1,100,210	$719,218	$1,518,306	$380,992
2020	$1,009,257	$879,727	$1,217,692	$129,530
2019	$1,071,973	$840,777	$1,056,955	$231,196